The global facial injectables market size was US$ 14.98 billion in 2021. The global facial injectables market size is forecast to reach US$ 40.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.8% during the forecast period from 2022 to 2030.

Dermal fillers are another name for facial injectables. These are FDA-approved medical device implants for use in the nasolabial folds (the lines extending from the sides of the nose to the borders of the mouth), cheeks, chin, lips, and backs of the hands to assist create a smoother or fuller appearance in the face. Furthermore, these facial injectable solutions are commonly used to cure early indicators of aging, such as wrinkles, and thereby improve aesthetic appearance.

Factors Influencing Market Growth

• Among the factors fueling the global market's growth include increasing aesthetic consciousness and the rising number of cosmetic procedures, the introduction of cost-effective facial injectables, and the growing geriatric population. 
• Side effects of available products, shortage of reimbursement policies sustaining cosmetic procedures, and the existence of counterfeit products and unlisted practitioners may slow down the adoption rate of the overall market.
• The rising demand to improve aesthetic beauty and increase in preference for minimally invasive procedures drive the global market.

Impact Analysis of COVID-19

The COVID-19 pandemic had a detrimental influence on the global market, resulting in the closure of cosmetic and dermatological clinics worldwide. In addition, because these procedures consider non-essential, they were among the first to see significant restrictions and cancellations in the healthcare market. This is the main reason for the significant decline in the growth of the facial injectables market in 2020. As vaccination rates continue to rise and restrictions are relaxed, the worldwide market has seen certain favorable trends. Cosmetic clinics and dermatological centers have seen an upsurge in virtual consultations. Another common trend is that demand for these injectables has increased significantly during COVID-19 lockdowns.

Regional Insights

The Asia Pacific region is forecast to have lucrative growth in the market during the forecast period. As a result of the rising focus on physical appearance in these countries such as India, Australia, and South Korea. In addition, increasing aesthetic business due to the growing purchasing power of the consumer. Thus, these factors are forecast to drive market growth in the region.

Leading Competitors

The leading prominent companies profiled in the global facial injectable market are:

• Allergan
• Hologic (cynosure)
• Johnson & Johnson
• Galderma
• Lumenis
• Solta Medical
• Syneron Candela
• Alma Laser
• Other Prominent Players

Scope of the Report

The global facial injectable market segmentation focuses on Type, Application, and Region.

Segmentation based on Type

• Wrinkle Relaxers
  • Botulinum Toxin
• Dermal Fillers
  • Collagen
  • Hyaluronic Acid
  • Fat Injection
  • Polylactic Acid
  • Polymethyl-methacrylate Microspheres (PMMA)
  • Calcium Hydroxylapatite
  • Other Types (Polyalkylimide etc.)

Segmentation based on Application

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Other Applications

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America